Protective CD8+ T lymphocytes in primates immunized with malaria sporozoites.
about
Immune mechanisms in malaria: new insights in vaccine developmentDendritic Cells and Their Multiple Roles during Malaria InfectionMalaria vaccines: identifying Plasmodium falciparum liver-stage targetsA glycolipid adjuvant, 7DW8-5, enhances CD8+ T cell responses induced by an adenovirus-vectored malaria vaccine in non-human primatesProtective efficacy of baculovirus dual expression system vaccine expressing Plasmodium falciparum circumsporozoite proteinDiscovery of Novel Plasmodium falciparum Pre-Erythrocytic Antigens for Vaccine DevelopmentIdentification of Novel Pre-Erythrocytic Malaria Antigen Candidates for Combination Vaccines with Circumsporozoite ProteinMalaria modeling: In vitro stem cells vs in vivo modelsComplex Minigene Library Vaccination for Discovery of Pre-Erythrocytic Plasmodium T Cell AntigensProtection against Plasmodium falciparum malaria by PfSPZ Vaccine.Using infective mosquitoes to challenge monkeys with Plasmodium knowlesi in malaria vaccine studiesNew gorilla adenovirus vaccine vectors induce potent immune responses and protection in a mouse malaria model.Sterile immunity to malaria after DNA prime/adenovirus boost immunization is associated with effector memory CD8+T cells targeting AMA1 class I epitopesTranslating the immunogenicity of prime-boost immunization with ChAd63 and MVA ME-TRAP from malaria naive to malaria-endemic populationsIgG2 antibodies against a clinical grade Plasmodium falciparum CSP vaccine antigen associate with protection against transgenic sporozoite challenge in mice.DNA prime/Adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunity.The case for a rational genome-based vaccine against malaria.Antigen-driven focal inflammatory death of malaria liver stagesComparative assessment of vaccine vectors encoding ten malaria antigens identifies two protective liver-stage candidates.Identification of Immunodominant Responses to the Plasmodium falciparum Antigens PfUIS3, PfLSA1 and PfLSAP2 in Multiple Strains of MiceProgress with viral vectored malaria vaccines: A multi-stage approach involving "unnatural immunity".Large screen approaches to identify novel malaria vaccine candidates.Measurement of ex vivo ELISpot interferon-gamma recall responses to Plasmodium falciparum AMA1 and CSP in Ghanaian adults with natural exposure to malariaPre-erythrocytic malaria vaccines: identifying the targets.Clinical trial in healthy malaria-naïve adults to evaluate the safety, tolerability, immunogenicity and efficacy of MuStDO5, a five-gene, sporozoite/hepatic stage Plasmodium falciparum DNA vaccine combined with escalating dose human GM-CSF DNAMosquito bite immunization with radiation-attenuated Plasmodium falciparum sporozoites: safety, tolerability, protective efficacy and humoral immunogenicityInducing humoral and cellular responses to multiple sporozoite and liver-stage malaria antigens using exogenous plasmid DNA.Ex vivo tetramer staining and cell surface phenotyping for early activation markers CD38 and HLA-DR to enumerate and characterize malaria antigen-specific CD8+ T-cells induced in human volunteers immunized with a Plasmodium falciparum adenovirus-vecRhesus macaque and mouse models for down-selecting circumsporozoite protein based malaria vaccines differ significantly in immunogenicity and functional outcomesDo you see what I see: Recognition of protozoan parasites by Toll-like receptors.Plasmodium knowlesi: a relevant, versatile experimental malaria model.Development of whole sporozoite malaria vaccines.Development of replication-deficient adenovirus malaria vaccines.Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infectionCellular immune response to DNA and vaccinia prime-boost immunization kills Plasmodium yoelii-infected hepatocytes in vitro.Ex vivo lymphocyte phenotyping during Plasmodium falciparum sporozoite immunization in humans.Profiling the Targets of Protective CD8+ T Cell Responses to Infection.Safety, Immunogenicity, and Protective Efficacy against Controlled Human Malaria Infection of Sporozoite Vaccine in Tanzanian Adults
P2860
Q21032484-B1D58792-A074-4EB1-A55F-62FE26E9EB9DQ26750593-0415AB3D-D01B-495D-98D7-3B8CAB64E68DQ26781372-A4C9D639-AD1B-419D-B801-0DEEA3C23CB9Q27303293-81F49E7D-CD92-4121-BE45-DDBC87A1F261Q27310086-60830A3F-5E54-42F3-9F6C-F224FCE688BFQ27972709-0B8A6B1B-6242-49D8-B384-DF49643B18E8Q27973488-3D6DBA65-845B-458D-84F3-389142152903Q28071293-C23D529C-6011-4E23-B36E-D0DE3245E55AQ28551311-F0C518F2-ECA0-423A-8873-066B64AF4C02Q30354426-67E904CA-2D3B-4C6F-BAD0-336603A0B5FFQ33805512-A9738273-BED1-45E6-9036-6B002E398BDFQ33868760-CB082CE9-94F1-4D3B-8586-267E93A41DE8Q34165879-0DCB9162-EBDF-47E7-8C5C-70980164915FQ34301461-CA9D5018-450E-4065-8683-5ECC45F11E74Q34400813-ED23B059-2970-4046-AE64-9BD3FD2028FFQ34606356-B08BBD71-9C9E-499D-8A6F-246EA456EDA3Q34999392-E44F7CBE-A151-46F8-A03B-CCB5915ECBE5Q35048008-8401C92D-930F-4B98-B32C-F1AEEFC3DBC3Q35813430-56A7737B-D372-4BB7-A876-F24B7AE5BEABQ35867348-D8682AA8-B2FF-4557-9489-FC1153D72609Q36394177-9050798B-BDCF-4A6D-AB61-C43752E7C853Q36510147-CF9569BF-AD71-46DE-813B-3B39BBA3C655Q36531046-5F48E2C8-A06F-47A1-AACF-4997C14CC81FQ36644236-370CD33F-DC40-4BCB-AF35-7A4DAF20DBEEQ36694820-85BE032D-892E-42BE-BE3E-EC67A4B30BA8Q37118222-B4E21E10-A6AA-4815-A109-1CC4E595E8A2Q37264722-DF7168B3-B103-43D2-9ED6-70C56E7E462CQ37285734-9DA4DDC8-479B-429F-A181-6BFA57AB135CQ37696415-3D090BD4-3F72-4DCD-8E64-F95A55B18026Q38266457-4B88E789-9656-4D91-964C-73503CEE2FACQ38784765-269CABD8-E202-4AEB-A66F-3C4112C14499Q38872073-A7F34044-EC78-43A7-B304-16C6F5E63662Q38949194-342CC673-8C8C-4F1E-B035-A60BB6A8F1A0Q38949224-07186CB6-EA52-4A1F-86FE-7E4AAD3EA380Q40213640-7765A3DA-CCFD-42E9-8A6E-046B45F55505Q41003777-2D0625DA-8698-4143-9BF6-9CC6E54E0A64Q41693606-E66720AE-D7E7-4834-A50B-8D76858C9173Q56349366-7B08890E-BF36-4187-9921-0591E06297A5
P2860
Protective CD8+ T lymphocytes in primates immunized with malaria sporozoites.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Protective CD8+ T lymphocytes in primates immunized with malaria sporozoites.
@ast
Protective CD8+ T lymphocytes in primates immunized with malaria sporozoites.
@en
Protective CD8+ T lymphocytes in primates immunized with malaria sporozoites.
@nl
type
label
Protective CD8+ T lymphocytes in primates immunized with malaria sporozoites.
@ast
Protective CD8+ T lymphocytes in primates immunized with malaria sporozoites.
@en
Protective CD8+ T lymphocytes in primates immunized with malaria sporozoites.
@nl
prefLabel
Protective CD8+ T lymphocytes in primates immunized with malaria sporozoites.
@ast
Protective CD8+ T lymphocytes in primates immunized with malaria sporozoites.
@en
Protective CD8+ T lymphocytes in primates immunized with malaria sporozoites.
@nl
P2860
P1433
P1476
Protective CD8+ T lymphocytes in primates immunized with malaria sporozoites.
@en
P2093
Chengyong George Jiang
Walter R Weiss
P2860
P304
P356
10.1371/JOURNAL.PONE.0031247
P407
P577
2012-02-15T00:00:00Z